Iron-Biofortified Rice Intervention in the Philippines

November 10, 2020 updated by: Cornell University

Randomized Trial of Iron-Biofortified Rice in Women in the Philippines

The objective of this randomized efficacy feeding trial was to determine the effects of consuming iron-biofortified rice on iron status in women, compared to non-biofortified rice. A randomized trial of biofortified rice (IR68144-2B-2-2-3), bred to enhance iron content, was conducted among women living in convents in the greater area of Manila, Philippines for 9 months.

Study Overview

Status

Completed

Conditions

Detailed Description

Iron deficiency is the most prevalent nutritional deficiency globally, with the highest burden in women of reproductive age and children. In this randomized controlled trial, 317 women aged 18-45 years living in convents in the greater Manila area, Philippines, were fed meals using either biofortified or commercially available rice for all meals, 7 days a week, for 9 months. Women living in convents in the greater Manila area were recruited for this study. These women represent a segment of the population at high risk for iron deficiency, consume large quantities of rice, and all of their meals are prepared and consumed in common kitchen and dining areas, respectively.

The investigators hypothesized that daily consumption of iron-biofortified rice (IR68144-2B-2-2-3) would improve hemoglobin, serum ferritin, and total body iron in 9 months, compared to control rice. In order to examine this hypothesis, the investigators conducted a randomized efficacy trial of iron-biofortified rice and iron status in among women living in convents in the greater area of Manila, Philippines for 9 months.

The objective of this randomized efficacy feeding trial was to determine the effects of consuming iron-biofortified rice on iron status in women, compared to non-biofortified rice.

The long-term goal of this study is to determine if iron bio-fortification of rice is an efficacious and potentially effective strategy to improve iron status of at-risk populations in resource-limited settings.

Study Type

Interventional

Enrollment (Actual)

288

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Laguna
      • Los Baños, Laguna, Philippines, 4031
        • University of the Philippines

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 45 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • Women (18-45 years old) living in convents in the greater Manila area
  • Hb ≥10.5 g/dL

Exclusion Criteria:

  • Current or history of gastrointestinal or hematological disorders
  • Taking iron supplements or medications that could interfere with hematopoiesis or dietary iron absorption
  • Hb <10.5 g/dL
  • Women expressed uncertainty in their ability to participate for the full (9 month) trial

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Iron-biofortified rice
Iron-biofortified rice (IR68144-2B-2-2-3)
Iron-biofortified rice (IR68144-2B-2-2-3)
Active Comparator: Control rice
Control rice (C4)
Control rice (C4), identical in appearance

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in serum ferritin
Time Frame: 9 months
Serum ferritin (SF)
9 months
Change in sTfR
Time Frame: 9 months
Soluble transferrin receptor (sTfR)
9 months
Change in TBI
Time Frame: 9 months
Total body iron (TBI)
9 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in hemoglobin among women who were anemic at baseline
Time Frame: 9 months
Changes in hemoglobin (Hb) in women who were anemic at baseline
9 months
Changes in SF among women who were non-anemic at baseline
Time Frame: 9 months
Changes in SF among women who were non-anemic at baseline
9 months
Changes in sTfR among women who were non-anemic at baseline
Time Frame: 9 months
Changes in sTfR among women who were non-anemic at baseline
9 months
Changes in TBI among women who were non-anemic at baseline
Time Frame: 9 months
Changes in TBI among women who were non-anemic at baseline
9 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Jere Haas, Cornell University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 1, 2002

Primary Completion (Actual)

December 31, 2003

Study Completion (Actual)

December 31, 2003

Study Registration Dates

First Submitted

November 4, 2020

First Submitted That Met QC Criteria

November 9, 2020

First Posted (Actual)

November 10, 2020

Study Record Updates

Last Update Posted (Actual)

November 13, 2020

Last Update Submitted That Met QC Criteria

November 10, 2020

Last Verified

November 1, 2020

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Iron-deficiency

Clinical Trials on Iron-biofortified rice

Subscribe